company

Cardiosolutions, Inc. is a development stage company focused on a novel alternative to open heart surgery to solve the problem of mitral and/or tricuspid regurgitation.

Currently, we are developing a pioneering technology, the Mitra-Spacer ™ designed to deliver an implant that will provide a sealing surface for the leaflets of the mitral or tricuspid valve, thereby significantly reducing or eliminating valve regurgitation.

Our goal is to provide a new therapeutic alternative for a wide range of patients of all ages who suffer from moderate to severe mitral regurgitation, including a portion of those who are currently in congestive heart failure. Our less invasive procedure has the potential to substantially reduce procedure time, expedite patient recovery and provide a less costly alternative to current treatment options.

  • Thomas Piemonte Chief Medical Officer

    Thomas Piemonte, M.D., FACC, Chief Medical Officer. Dr.Piemonte is the Director,Interventional Cardiovascular Medicine and Cardiac Catheterization Laboratory at the Lahey Clinic in Burlington, Massachusetts. Dr. Piemonte is a graduate of The College of the Holy Cross and New York Medical College. He was an intern, resident and Chief Resident at St. Elizabeth’s Hospital in Boston, Massachusetts. Dr. Piemonte is board certified in cardiology, interventional cardiology and internal medicine. In addition to Dr. Piemonte’s practice and academic activities, he is the President of Project Pacer International, a non-profit organization committed to delivering cardiac care to third world countries. He has participated in several clinical studies and he has written and lectured extensively in his field. Dr. Piemonte also serves as a Clinical Instructor at Harvard Medical School.Board of Directors.

  • Michael Benoit C.E.O.

    Michael is active in private equity investing as an angel investor, board member, mentor, technical adviser and strategic partner. Michael served or serves on the board of Mtuitive, Spirus Medical, Cardiosolutions and AngioLink. He also helped found and chair Bay Angels, LLC, an angel group focused on seed level investment. Michael was the founder and CEO of Vista High-Tech Resources, Inc., and was at the helm of the company for 15 years before it was sold to Compuware in 1999

  • Steven TallaridaChairman of Board of Directors

    Steven J. Tallarida, President and Chairman of the Board. Mr. Tallarida brings to Cardiosolutions his expertise and experience from over 30 years of manufacturing medical products. Mr. Tallarida is an owner and Director of Primo Medical Group, Inc. and has been President of Primo Medical Group (F/K/A STD Med. Inc.) for over 25 years, during which time Mr. Tallarida transformed Primo Medical from a defense manufacturing company to an ISO 13485/ISO 9001 certified, medical device design and manufacturing company. Mr. Tallarida graduated from American University. In addition to co-founding Cardiosolutions, Mr. Tallarida is co-founder of Angiolink and co-founder and member of the Board of Directors at Arthrosurface, Inc., Spirus Medical, Versago Vascular Access and Saphena Medical.

  • Marc GoldbergMember

    Marc Goldberg, J.D., M.B.A., a is co-founder and Managing Partner of BioVentures Investors. He brings well over 30 years of managerial and investment experience in the healthcare sector. Marc is a member of the Harvard Medical School Advisory Council on Discovery, serves as Chairman Emeritus of the Harvard Varsity Club and is a member of the Board of Directors for both Step by Step Supportive Services and the Richi Childhood Cancer Foundation. Marc currently serves on the Board of Directors for Endotronix, Verax Biomedical, POC Medical, Cardiosolutions, HydroCision, sGC Pharma and Rachiotek.Marc earned his A.B. from Harvard College, his J.D. from Harvard Law School, and his M.B.A. from Harvard Business School.

  • Andrea PatisteasMember

    Andrea Patisteas, Director. Ms. Patisteas, one of the founders of Cardiosolutions, is currently Senior Executive Vice President at Primo Medical Group, Inc. Ms. Patisteas has worked in the medical device design and manufacturing field for over 27 years. Ms. Patisteas is on the Board of Directors of The Ocular Immunology Foundation an organization dedicated to finding cures for ocular inflammatory disease. She also sits on the Board of Overseers for Big Brothers Big Sisters of Massachusetts Bay. She holds a B.S. Ed from BSU, and a M.S. in Counseling/Business Support from Northeastern University. Ms. Patisteas is also The CEO and co-founder of Versago Vascular Access, a co-founder of Angiolink, and a co-founder and Director at Arthrosurface Incorporated, Spirus Medical Inc. and Saphena Medical.

  • Michael BenoitC.E.O.

    Michael is active in private equity investing as an angel investor, board member, mentor, technical adviser and strategic partner. Michael served or serves on the board of Mtuitive, Spirus Medical, Cardiosolutions and AngioLink. He also helped found and chair Bay Angels, LLC, an angel group focused on seed level investment. Michael was the founder and CEO of Vista High-Tech Resources, Inc., and was at the helm of the company for 15 years before it was sold to Compuware in 1999


Cardiosolutions, Inc. 375 West Street, West Bridgewater, MA 02379